These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24876727)

  • 61. [Moxibustion relieves abdominal hypersensitivity and diarrhea by regulating colonic 5-hydroxytryptamine signaling pathway in rats with diarrhea type irritable bowel syndrome].
    Tong L; Wu LB; Li N; Cheng HL; Cai RL; Chu HR
    Zhen Ci Yan Jiu; 2020 Jul; 45(7):535-40. PubMed ID: 32705826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
    Camilleri M; Ford AC
    Handb Exp Pharmacol; 2017; 239():75-113. PubMed ID: 27995391
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome.
    Pisipati S; Connor BA; Riddle MS
    Curr Opin Infect Dis; 2020 Oct; 33(5):411-418. PubMed ID: 32833689
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.
    Tsang SW; Auyeung KK; Bian ZX; Ko JK
    Curr Neuropharmacol; 2016; 14(8):842-856. PubMed ID: 27009115
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Bidirectional regulation of acupuncture: a subgroup analysis of multicenter randomized controlled trial of acupuncture with
    Guo J; Sun JH; Chen L; Geng H; Yang GH; Shen RR; Ding M; Lu J; Liu L; Fang XD; Pei LX
    Zhongguo Zhen Jiu; 2021 Aug; 41(8):845-50. PubMed ID: 34369692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Study on the Mechanism Underlying the Regulation of the NMDA Receptor Pathway in Spinal Dorsal Horns of Visceral Hypersensitivity Rats by Moxibustion.
    Wang LD; Zhao JM; Huang RJ; Tan LY; Hu ZH; Weng ZJ; Wang K; Wu HG; Liu HR
    Evid Based Complement Alternat Med; 2016; 2016():3174608. PubMed ID: 27200098
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The pathophysiology of irritable bowel syndrome].
    Zouiten ML; Karoui S; Boubaker J; Fekih M; Mechmeche R; Filali A
    Tunis Med; 2006 May; 84(5):269-74. PubMed ID: 16915774
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent developments in the pathophysiology of irritable bowel syndrome.
    El-Salhy M
    World J Gastroenterol; 2015 Jul; 21(25):7621-36. PubMed ID: 26167065
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome.
    Barbara G; Cremon C; De Giorgio R; Dothel G; Zecchi L; Bellacosa L; Carini G; Stanghellini V; Corinaldesi R
    Curr Gastroenterol Rep; 2011 Aug; 13(4):308-15. PubMed ID: 21537962
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative effect of electroacupuncture and moxibustion on the expression of substance P and vasoactive intestinal peptide in patients with irritable bowel syndrome.
    Zhenzhong L; Xiaojun Y; Weijun T; Yuehua C; Jie S; Jimeng Z; Anqi W; Chunhui B; Yin S
    J Tradit Chin Med; 2015 Aug; 35(4):402-10. PubMed ID: 26427109
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.
    Zhao JM; Wu LY; Liu HR; Hu HY; Wang JY; Huang RJ; Shi Y; Tao SP; Gao Q; Zhou CL; Qi L; Ma XP; Wu HG
    World J Gastroenterol; 2014 Oct; 20(37):13563-72. PubMed ID: 25309087
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion.
    Anastasi JK; McMahon DJ; Kim GH
    Gastroenterol Nurs; 2009; 32(4):243-55. PubMed ID: 19696601
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acupuncture for treatment of irritable bowel syndrome.
    Manheimer E; Cheng K; Wieland LS; Min LS; Shen X; Berman BM; Lao L
    Cochrane Database Syst Rev; 2012 May; 5(5):CD005111. PubMed ID: 22592702
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Irritable Bowel Syndrome: A Clinical Review.
    Cashman MD; Martin DK; Dhillon S; Puli SR
    Curr Rheumatol Rev; 2016; 12(1):13-26. PubMed ID: 26717952
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Probiotic agents in the treatment of irritable bowel syndrome.
    Guslandi M
    J Int Med Res; 2007; 35(5):583-9. PubMed ID: 17900396
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Latest Insights on the Pathogenesis of Irritable Bowel Syndrome.
    Videlock EJ; Chang L
    Gastroenterol Clin North Am; 2021 Sep; 50(3):505-522. PubMed ID: 34304785
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
    Hong SN; Rhee PL
    World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Progress of Researches on Relationship between Acu-moxibustion Induced Modulation of Small Intestinal Motility and Autonomic Nervous Activity ].
    Zhang N; Yu Z; Xu B
    Zhen Ci Yan Jiu; 2014 Dec; 39(6):508-11. PubMed ID: 25632580
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China.
    Liu J; Hou X
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():88-93. PubMed ID: 21443718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of water extracts from Cynanchum thesioides (Freyn) K. Schum. on visceral hypersensitivity and gut microbiota profile in maternally separated rats.
    Lingpeng P; Jingzhu S; Wei L; Enqi W; Yaqin L
    J Ethnopharmacol; 2021 Jan; 264():113352. PubMed ID: 32891821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.